Pathogenic mutations in other high-penetrance genes (i.e., TP53, PTEN, CDH1, NGO11, or PALB2) other than BRCA1/2 increase the risk of breast cancer by more than 4-fold and are responsible for 25% of all hereditary breast cancers [6]. This evidence concerns the gene PTEN and breast carcinoma.